Literature DB >> 20521938

Impact of human activities on the ecology of nontuberculous mycobacteria.

Joseph O Falkinham1.   

Abstract

Nontuberculous mycobacteria (NTM) are environmental opportunistic pathogens of humans and animals. They are found in a wide variety of habitats to which humans are exposed, including drinking water distribution systems and household water and plumbing. In that regard, they are distinct from their obligate pathogenic relatives, the members of the Mycobacterium tuberculosis complex. Owing to the presence of NTM in the human environment, human activities have had direct impacts on their ecology and thereby their epidemiology. NTM are oligotrophic, able to grow at low organic matter concentrations and over a wide range of temperatures, and even at low oxygen concentrations. Thus, NTM are normal inhabitants of natural waters and drinking waters. Discovery of the presence of NTM-polluted soils is not surprising in light of the ability of NTM to degrade a variety of hydrocarbon pollutants. A major human activity selecting for the growth and predominance of mycobacteria in habitats is disinfection. In comparison to other bacteria, NTM are disinfectant, heavy metal and antibiotic resistant. Therefore, the use of any antimicrobial agent selects for mycobacteria. Use of disinfectant in drinking water treatment selects for mycobacteria that can grow and come to proliferate in drinking water distribution systems in the absence of disinfectant-sensitive competing microorganisms. NTM selection may also occur as a consequence of antibiotics in drinking water sources.

Entities:  

Mesh:

Year:  2010        PMID: 20521938     DOI: 10.2217/fmb.10.53

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  27 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.

Authors:  Jennifer Adjemian; Kenneth N Olivier; Amy E Seitz; Steven M Holland; D Rebecca Prevots
Journal:  Am J Respir Crit Care Med       Date:  2012-02-03       Impact factor: 21.405

3.  Production, crystallization and structure determination of a mycobacterial glucosylglycerate hydrolase.

Authors:  Tatiana Barros Cereija; Susana Alarico; Nuno Empadinhas; Pedro José Barbosa Pereira
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-09-01       Impact factor: 1.056

Review 4.  Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.

Authors:  Javeed A Shah; Cecilia S Lindestam Arlehamn; David J Horne; Alessandro Sette; Thomas R Hawn
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

5.  Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to 2014.

Authors:  N El-Zeenni; S Chanoine; C Recule; J-P Stahl; M Maurin; B Camara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-24       Impact factor: 3.267

6.  Non-tuberculous mycobacteria mimic of MDR-TB infection in Pott's disease.

Authors:  Manoj Kumar; Sheetal Verma; Tapan N Dhole; Raj Kumar
Journal:  BMJ Case Rep       Date:  2016-09-23

7.  Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease.

Authors:  Jennifer Adjemian; D Rebecca Prevots; Jack Gallagher; Kylee Heap; Renu Gupta; David Griffith
Journal:  Ann Am Thorac Soc       Date:  2014-01

8.  The Burden of Pulmonary Nontuberculous Mycobacterial Disease in the United States.

Authors:  Sara E Strollo; Jennifer Adjemian; Michael K Adjemian; D Rebecca Prevots
Journal:  Ann Am Thorac Soc       Date:  2015-10

9.  Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.

Authors:  Andrés Obregón-Henao; Kimberly A Arnett; Marcela Henao-Tamayo; Lisa Massoudi; Elizabeth Creissen; Koen Andries; Anne J Lenaerts; Diane J Ordway
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

10.  Host response to nontuberculous mycobacterial infections of current clinical importance.

Authors:  Ian M Orme; Diane J Ordway
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.